Glenview Trust Co Cuts Stake in UnitedHealth Group Incorporated $UNH

Glenview Trust Co decreased its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 27.6% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 11,166 shares of the healthcare conglomerate’s stock after selling 4,265 shares during the period. Glenview Trust Co’s holdings in UnitedHealth Group were worth $3,856,000 as of its most recent filing with the SEC.

Several other institutional investors have also bought and sold shares of the company. Norges Bank purchased a new stake in shares of UnitedHealth Group during the second quarter worth $3,837,207,000. Berkshire Hathaway Inc purchased a new stake in UnitedHealth Group in the 2nd quarter worth approximately $1,572,193,000. Dodge & Cox grew its position in shares of UnitedHealth Group by 117.7% during the 2nd quarter. Dodge & Cox now owns 8,750,560 shares of the healthcare conglomerate’s stock valued at $2,729,912,000 after purchasing an additional 4,730,192 shares in the last quarter. Lone Pine Capital LLC purchased a new stake in shares of UnitedHealth Group in the second quarter worth $528,273,000. Finally, Amundi grew its position in UnitedHealth Group by 33.8% during the second quarter. Amundi now owns 6,191,871 shares of the healthcare conglomerate’s stock worth $1,904,372,000 after buying an additional 1,565,245 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of research analyst reports. UBS Group dropped their price target on UnitedHealth Group from $430.00 to $410.00 and set a “buy” rating for the company in a research report on Wednesday, January 28th. Weiss Ratings restated a “hold (c-)” rating on shares of UnitedHealth Group in a research report on Wednesday, January 21st. TD Cowen increased their target price on UnitedHealth Group from $335.00 to $338.00 and gave the company a “hold” rating in a research note on Thursday, October 30th. Sanford C. Bernstein reiterated an “outperform” rating on shares of UnitedHealth Group in a report on Wednesday, January 28th. Finally, Evercore raised UnitedHealth Group to a “strong-buy” rating in a report on Tuesday, January 6th. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating, nine have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Moderate Buy” and an average target price of $372.13.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock opened at $289.04 on Wednesday. The company has a quick ratio of 0.82, a current ratio of 0.79 and a debt-to-equity ratio of 0.72. The company’s fifty day simple moving average is $319.62 and its two-hundred day simple moving average is $324.38. The firm has a market cap of $261.82 billion, a PE ratio of 21.91, a price-to-earnings-growth ratio of 1.35 and a beta of 0.41. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $606.36.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.09 by $0.02. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The company had revenue of $113.22 billion for the quarter, compared to analysts’ expectations of $113.38 billion. During the same period last year, the firm earned $6.81 earnings per share. UnitedHealth Group’s quarterly revenue was up 12.3% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.